• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

Chromosome band 1p36 contains a putative tumor suppressor gene important in the evolution of chronic myelocytic leukemia.

作者信息

Mori N, Morosetti R, Spira S, Lee S, Ben-Yehuda D, Schiller G, Landolfi R, Mizoguchi H, Koeffler H P

机构信息

Departments of Medicine and Clinical Pathology, Cedars-Sinai Medical Center, UCLA School of Medicine, Los Angeles, CA, USA.

出版信息

Blood. 1998 Nov 1;92(9):3405-9.

PMID:9787180
Abstract

Chronic myelocytic leukemia (CML) is a common neoplasm of hematopoietic pluripotent stem cells. Although the evolution from chronic phase to blast crisis (BC) in CML patients is an inevitable clinical feature, little is understood about the mechanisms responsible for the transformation. We have previously performed allelotype analysis in CML BC and have detected frequent loss of heterozygosity (LOH) on the short arm of chromosome 1. To know the common region of LOH where a putative tumor suppressor gene may reside, deletional mapping was performed using 33 microsatellite markers spanning chromosome 1 in 30 patients with CML BC (21 myeloid and 9 lymphoid). DNA was extracted from slides of bone marrow smears or from bone marrow mononuclear cells. In each patient, DNA from chronic phase was analyzed alongside DNA from either their BC or accelerated phase. Allelic loss on 1p was observed in 14 of the 30 individuals (47%): 10 of the 21 myeloid and 4 of the 9 lymphoid BC cases. Serial cytogenetic information was available in 10 cases with LOH on 1p; interestingly, deletions in this region were not detected. Two samples showed LOH at all informative loci on 1p, whereas the other 12 samples showed LOH on at least one but not all loci on 1p. The common region of LOH resided proximal to D1S508 and distal to D1S507 (1p36). Our results suggest that a tumor suppressor gene that frequently plays an important role in the evolution to BC resides on 1p36 in CML.

摘要

相似文献

1
Chromosome band 1p36 contains a putative tumor suppressor gene important in the evolution of chronic myelocytic leukemia.
Blood. 1998 Nov 1;92(9):3405-9.
2
Progression of myelodysplastic syndrome: allelic loss on chromosomal arm 1p.
Br J Haematol. 2003 Jul;122(2):226-30. doi: 10.1046/j.1365-2141.2003.04434.x.
3
Allelotype analysis in the evolution of chronic myelocytic leukemia.慢性粒细胞白血病演变中的等位基因型分析。
Blood. 1997 Sep 1;90(5):2010-4.
4
Increase of bcr-abl chimeric mRNA expression in tumor cells of patients with chronic myeloid leukemia precedes disease progression.慢性髓性白血病患者肿瘤细胞中bcr-abl嵌合mRNA表达的增加先于疾病进展。
Blood. 1995 Sep 15;86(6):2371-8.
5
Consistent loss of heterozygosity at 14Q32 in lymphoid blast crisis of chronic myeloid leukemia.
Leuk Lymphoma. 2000 Oct;39(3-4):385-90. doi: 10.3109/10428190009065838.
6
No correlation between locations of bcr breakpoints and clinical states in Ph1-positive CML patients.在Ph1阳性慢性粒细胞白血病患者中,bcr断点位置与临床状态之间无相关性。
Leukemia. 1989 Jul;3(7):492-6.
7
The TGF-beta type II receptor in chronic myeloid leukemia: analysis of microsatellite regions and gene expression.慢性粒细胞白血病中的转化生长因子-β II 型受体:微卫星区域及基因表达分析
Leukemia. 1999 Apr;13(4):535-41. doi: 10.1038/sj.leu.2401384.
8
Allelic losses at 1p36 and 19q13 in gliomas: correlation with histologic classification, definition of a 150-kb minimal deleted region on 1p36, and evaluation of CAMTA1 as a candidate tumor suppressor gene.胶质瘤中1p36和19q13的等位基因缺失:与组织学分类的相关性、1p36上150kb最小缺失区域的定义以及CAMTA1作为候选肿瘤抑制基因的评估
Clin Cancer Res. 2005 Feb 1;11(3):1119-28.
9
No evidence for microsatellite instability or consistent loss of heterozygosity at selected loci in chronic myeloid leukaemia blast crisis.慢性髓性白血病急变期在选定基因座处无微卫星不稳定性或杂合性持续缺失的证据。
Leukemia. 1994 Nov;8(11):1923-8.
10
Abnormality of c-kit oncoprotein in certain patients with chronic myelogenous leukemia--potential clinical significance.某些慢性粒细胞白血病患者中c-kit癌蛋白的异常——潜在的临床意义。
Leukemia. 2002 Feb;16(2):170-7. doi: 10.1038/sj.leu.2402341.

引用本文的文献

1
Overexpression of chromodomain helicase DNA binding protein 5 (CHD5) inhibits cell proliferation and induces cell cycle arrest and apoptosis in chronic myeloid leukemia.染色体结构域解旋酶DNA结合蛋白5(CHD5)的过表达抑制慢性髓性白血病细胞的增殖并诱导细胞周期停滞和凋亡。
Transl Cancer Res. 2021 Feb;10(2):768-778. doi: 10.21037/tcr-20-2276.
2
Association between TP53 genetic polymorphisms and the methylation and expression of miR-34a, 34b/c in colorectal cancer tissues.结直肠癌组织中TP53基因多态性与miR-34a、34b/c甲基化及表达的相关性
Oncol Lett. 2019 May;17(5):4726-4734. doi: 10.3892/ol.2019.10092. Epub 2019 Mar 1.
3
Silencing of CHD5 gene by promoter methylation in leukemia.
白血病中CHD5基因启动子甲基化导致的基因沉默
PLoS One. 2014 Jan 13;9(1):e85172. doi: 10.1371/journal.pone.0085172. eCollection 2014.
4
The tumor suppressor Chd5 is induced during neuronal differentiation in the developing mouse brain.肿瘤抑制因子Chd5在发育中的小鼠大脑神经元分化过程中被诱导表达。
Gene Expr Patterns. 2013 Dec;13(8):482-9. doi: 10.1016/j.gep.2013.09.003. Epub 2013 Oct 9.
5
Identification of copy number alterations by array comparative genomic hybridization in patients with late chronic or accelerated phase chronic myeloid leukemia treated with imatinib mesylate.通过使用甲磺酸伊马替尼治疗的慢性期或加速期慢性髓性白血病患者的阵列比较基因组杂交技术鉴定拷贝数改变。
Int J Hematol. 2011 Apr;93(4):465-473. doi: 10.1007/s12185-011-0796-9. Epub 2011 Mar 9.
6
Anticancer activity of the PR domain of tumor suppressor RIZ1.肿瘤抑制因子 RIZ1 的 PR 结构域的抗癌活性。
Int J Med Sci. 2011 Feb 21;8(2):161-7. doi: 10.7150/ijms.8.161.
7
Pro-apoptotic and anti-proliferative effects of mitofusin-2 via Bax signaling in hepatocellular carcinoma cells.线粒体融合蛋白 2 通过 Bax 信号通路在肝癌细胞中的促凋亡和抗增殖作用。
Med Oncol. 2012 Mar;29(1):70-6. doi: 10.1007/s12032-010-9779-6. Epub 2010 Dec 29.
8
Throwing the cancer switch: reciprocal roles of polycomb and trithorax proteins.打开癌症开关:多梳蛋白和 trithorax 蛋白的相互作用。
Nat Rev Cancer. 2010 Oct;10(10):669-82. doi: 10.1038/nrc2931.
9
Mig-6 controls EGFR trafficking and suppresses gliomagenesis.Mig-6 控制 EGFR 运输并抑制神经胶质瘤发生。
Proc Natl Acad Sci U S A. 2010 Apr 13;107(15):6912-7. doi: 10.1073/pnas.0914930107. Epub 2010 Mar 29.
10
SNP array analysis of tyrosine kinase inhibitor-resistant chronic myeloid leukemia identifies heterogeneous secondary genomic alterations.SNP array 分析酪氨酸激酶抑制剂耐药的慢性髓性白血病发现了异质性的二次基因组改变。
Blood. 2010 Feb 4;115(5):1049-53. doi: 10.1182/blood-2009-03-210377. Epub 2009 Dec 2.